Mandible osteoradionecrosis after high-dose radiation therapy for head and neck cancers: risk factors and dosimetric analysis

Chronopoulos A, Zarra T, Ehrenfeld M, et al. Osteoradionecrosis of the jaws: definition, epidemiology, staging and clinical and radiological findings. A concise review. Int Dent J. 2018 Feb;68(1):22–30.

https://doi.org/10.1111/idj.12318 DOI: https://doi.org/10.1111/idj.12318

Rogers SN, D’Souza JJ, Lowe D, et al. Longitudinal evaluation of health-related quality of life after osteoradionecrosis of the mandible. Br J Oral Maxillofac Surg. 2015 Aug;53(9):854–7.

https://doi.org/10.1016/j.bjoms.2015.07.008 DOI: https://doi.org/10.1016/j.bjoms.2015.07.008

Tsai CJ, Hofstede TM, Sturgis EM, et al. Osteoradionecrosis and radiation dose to the mandible in patients with oropharyngeal cancer. Int J Radiat Oncol Biol Phys. 2013 Feb;85(2):415–20.

https://doi.org/10.1016/j.ijrobp.2012.05.032 DOI: https://doi.org/10.1016/j.ijrobp.2012.05.032

Maesschalck T, Dulguerov N, Caparrotti F, et al. Comparison of the incidence of osteo-radionecrosis with conventional radiotherapy and intensity-modulated radi-otherapy. Head Neck. 2016 Nov;38(11):1695–702.

https://doi.org/10.1002/hed.24505 DOI: https://doi.org/10.1002/hed.24505

MD Anderson Head and Neck Cancer Symptom Working Group. Dose-volume correlates of mandibular osteoradionecrosis in Oropharynx cancer patients receiving intensity-modulated radiotherapy: results from a case-matched comparison. Radiother Oncol. 2017 Aug;124(2):232–9.

https://doi.org/10.1016/j.radonc.2017.06.026 DOI: https://doi.org/10.1016/j.radonc.2017.06.026

Aarup-Kristensen S, Hansen CR, Forner L, et al. Osteoradionecrosis of the mandible after radiotherapy for head and neck cancer: risk factors and dose-volume correlat-ions. Acta Oncol. 2019;58(10):1373–7.

https://doi.org/10.1080/0284186X.2019.1643037 DOI: https://doi.org/10.1080/0284186X.2019.1643037

Miniello TG, Araújo JP, Silva MLG, et al. Influence of bisphosphonates on clinical features of osteoradionecrosis of the maxilla and mandible. Oral Dis. 2019 Jul;25(5):1344–51.

https://doi.org/10.1111/odi.13081 DOI: https://doi.org/10.1111/odi.13081

Kubota H, Miyawaki D, Mukumoto N, et al. Risk factors for osteoradionecrosis of the jaw in patients with head and neck squamous cell carcinoma. Radiat Oncol. 2019 Jul;16(1):1.

https://doi.org/10.1186/s13014-020-01701-5 DOI: https://doi.org/10.1186/s13014-020-01701-5

De Felice F, Musio D, Tombolini V. Osteoradionecrosis: an old toxicity in the IMRT era? Oral Oncol. 2019 Jun;51(6):e60–1.

https://doi.org/10.1016/j.oraloncology.2015.03.002 DOI: https://doi.org/10.1016/j.oraloncology.2015.03.002

Thorn JJ, Hansen HS, Specht L, et al. Osteoradionecrosis of the jaws: clinical characteris-tics and relation to the field of irradiation. J Oral Maxillofac Surg. 2000 Oct;58(10):1088–95.

https://doi.org/10.1053/joms.2000.9562 DOI: https://doi.org/10.1053/joms.2000.9562

Gevorgyan A, Wong K, Poon I, et al. Osteoradionecrosis of the mandible: a case series at a single institution. J Otolaryngol Head Neck Surg. 2013 Sep;42(1):46.

https://doi.org/10.1186/1916-0216-42-46 DOI: https://doi.org/10.1186/1916-0216-42-46

Studer G, Bredell M, Studer S, et al. Risk profile for osteoradionecrosis of the mandible in the IMRT era. Strahlenther Onkol. 2016 Jan;192(1):32–9.

https://doi.org/10.1007/s00066-015-0875-6 DOI: https://doi.org/10.1007/s00066-015-0875-6

Rathy R, Sunil S, Nivia M. Osteoradionecrosis of mandible: case report with review of lit-erature. Contemp Clin Dent. 2013 Apr;4(2):251–3.

https://doi.org/10.4103/0976-237X.114882 DOI: https://doi.org/10.4103/0976-237X.114882

Jensen K, Friborg J, Hansen CR, et al. The Danish Head and Neck Cancer Group (DAHAN-CA) 2020 radiotherapy guidelines. Radiother Oncol. 2020 Oct;151:149–51.

https://doi.org/10.1016/j.radonc.2020.07.037 DOI: https://doi.org/10.1016/j.radonc.2020.07.037

Ben-David MA, Diamante M, Radawski JD, et al. Lack of osteoradionecrosis of the mandible after intensity-modulated radiotherapy for head and neck cancer: likely contributions of both dental care and improved dose distributions. Int J Radiat Oncol Biol Phys. 2007 Jun;68(2):396–402.

https://doi.org/10.1016/j.ijrobp.2006.11.059 DOI: https://doi.org/10.1016/j.ijrobp.2006.11.059

Rulach R, Chalmers A, Currie S, et al. Multi-criteria optimisation is effective at reducing dose to organs at risk in non-small cell lung cancer (NSCLC). Re-irradiation. Int J Radiat Oncol Biol Phys. 2019 Sep;105:783.

https://doi.org/10.1016/j.ijrobp.2019.06.745 DOI: https://doi.org/10.1016/j.ijrobp.2019.06.745